Oncodesign Company
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Technology:
Precision Medicine
Industry:
Early and Preclinical Drug Development
Headquarters:
Dijon, Bourgogne, France
Founded Date:
1995-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
3
Total Funding:
29400000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2009-08-26
Last Funding Type:
Undisclosed
Register and Claim Ownership